Ticker Scorecard - IVVD Basics Company: Invivyd, Inc. IPO Date: August 6, 2022 Sector: Healthcare Industry: Biotech Market Cap: $211.72M Activated in VL: True Average Daily Range Avg Daily Range: $0.09 | 5.11% Avg Daily Range (30 D): $0.15 | 15.45% Avg Daily Range (90 D): $0.08 | 8.98% Institutional Daily Volume Avg Daily Volume: 1.54M Avg Daily Volume (30 D): 22.02M Avg Daily Volume (90 D): 7.92M Trade Size Avg Trade Size (Sh.): 310 Avg Trade Size (Sh.) (30 D): 504 Avg Trade Size (Sh.) (90 D): 479 Institutional Trades Total Inst.Trades: 35 Avg Inst. Trade: $2.72M Avg Inst. Trade (30 D): $.68M Avg Inst. Trade (90 D): $.96M Avg Inst. Trade Volume: 1.06M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.12M Avg Closing Trade (30 D): $.55M Avg Closing Trade (90 D): $.55M Avg Closing Volume: 2.15M     News Nov 6, 2024 @ 1:01 PM Invivyd to Participate in the Guggenheim Securitie... Source: N/A Nov 6, 2024 @ 12:01 PM Invivyd to Host Third Quarter 2024 Financial Resul... Source: N/A Oct 16, 2024 @ 11:01 AM Invivyd to Present PEMGARDAâ„¢ (pemivibart) Da... Source: Globe Newswire Jul 1, 2024 @ 11:01 AM Invivyd Announces its Addition to the Russell 2000... Source: Invivyd Jun 14, 2024 @ 11:01 AM Invivyd Announces Antiviral Activity of VYD222 (pe... Source: Invivyd Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.51 $-.4 $-.38 Diluted EPS $-.51 $-.4 $-.38 Revenue $ 9.3M $ 2.26M $ M Gross Profit $ $ $ Net Income / Loss $ -60.74M $ -47.25M $ -43.5M Operating Income / Loss $ -62.31M $ -49.25M $ -46.09M Cost of Revenue $ $ $ Net Cash Flow $ -41.01M $ -41.51M $ -11.25M PE Ratio